NCT01856101 2019-04-10
BEZ235
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 2 Terminated
Clinical Trials
3 trialsNCT00378703 2018-11-14
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00353301 2014-04-14
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma
University of Colorado, Denver
Phase 2 Completed